Background
Pregnant women in Malawi are at risk of selenium deficiency, which may have adverse effects on pregnancy outcomes. Interventions for improving selenium status are needed.
Objectives
The effect of provision of small-quantity lipid-based nutrient supplements (SQ-LNS) to Malawian women during pregnancy on their plasma selenium concentrations was assessed at 36 wk gestation.
Methods
Pregnant women (≤20 wk gestation) were randomized to receive daily either: 1) iron and folic acid (IFA); 2) multiple micronutrients (MMN; 130 µg selenium/capsule) or 3) SQ-LNS (130 µg selenium/20 g). Plasma selenium concentrations were measured by ICP-MS at baseline and after at least 16 wk of intervention (at 36 wk gestation) and compared by intervention group.
Results
At 36 wk gestation, median (Q1, Q3) plasma selenium concentrations (µmol/L) were 0.96 (0.73, 1.23), 0.94 (0.78, 1.18), and 1.01 (0.85, 1.28) in the IFA, MMN and SQ-LNS groups respectively. Geometric mean (GM) plasma selenium concentration was 5.4% (95%CI:1.8%, 9.0%) higher in the SQ-LNS group than in the MMN group and tended to be higher than in the IFA group (+4.2% (95%CI: 1.0%, 7.8%). The prevalence of adjusted plasma selenium concentrations < 1 µmol/L was 55.1%, 57.8% and 47.3% in the IFA, MMN, and SQ-LNS groups, respectively; it was lower in the SQ-LNS group than in the MMN group, OR = 0.44 (95%CI:0.24, 0.83), and tended to be lower than in the IFA group, OR = 0.54 (95%CI:0.29, 1.03). There was a significant interaction between baseline plasma selenium concentration and intervention group (P = 0.003). In the lowest tertile of baseline selenium concentrations, GM (95%CI) plasma selenium concentration was higher, and the prevalence of low values was lower in the SQ-LNS group compared to the MMN and IFA groups at 36 wk gestation (P ≤ 0.007).
Conclusion
Provision of SQ-LNS containing selenium to pregnant women can be an effective strategy for improving their selenium status. Clinicaltrials.gov identifier: NCT01239693.